In Reply: Antiobesity drug therapy
Cleve Clin J Med
.
2021 Dec 2;88(12):657-658.
doi: 10.3949/ccjm.88c.12002.
Authors
Yael Mauer
1
,
Marcie Parker
2
,
Sangeeta Kashyap
3
4
Affiliations
1
Department of Internal Medicine and Geriatrics, Cleveland Clinic, Cleveland, OH.
2
Ambulatory Care Clinical Specialist, Department of Pharmacy, Cleveland Clinic, Beachwood, OH.
3
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case, Western Reserve University.
4
Associate Program Director, Endocrinology, Diabetes, and Metabolism Fellowship Cleveland Clinic Cleveland, OH.
PMID:
34857600
DOI:
10.3949/ccjm.88c.12002
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Obesity Agents* / adverse effects
Humans
Obesity / drug therapy
Practice Patterns, Physicians'
Substances
Anti-Obesity Agents